Hwaseong-si, South Korea

Hongchul Yoon

USPTO Granted Patents = 1 

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Hongchul Yoon

Introduction: Hongchul Yoon, an accomplished inventor based in Hwaseong-si, South Korea, has made significant contributions to the field of pharmaceutical innovations. With a keen focus on CFTR modulation, his work reflects the synergy between chemistry and medicine.

Latest Patents: Hongchul Yoon holds a patent titled "Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators." This patent discloses CFTR modulator and phosphodiesterase 4 (PDE4) inhibitor compounds, offering valuable methods for treating various eye diseases and CFTR-related indications. The disclosed compounds demonstrate potential for inhibiting PDE4 in biological systems, presenting solutions for treating inflammatory diseases and disorders.

Career Highlights: Currently employed at Il Dong Pharmaceutical Co., Ltd., Hongchul Yoon has established himself as a key figure in the advancement of pharmaceutical compounds. His research not only contributes to the company’s portfolio but also advances the understanding of CFTR-related therapies.

Collaborations: Throughout his career, Hongchul has collaborated with talented professionals, including Myongjae Lee and Changmok Oh. These partnerships have sparked innovation and enabled transformative discoveries in his field.

Conclusion: Hongchul Yoon's dedication to innovation and drug development underscores his pivotal role in the pharmaceutical industry. As he continues to explore new avenues in CFTR modulation, his contributions promise to enhance therapeutic options for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…